The Personalised Cancer Medicine Program at Karolinska Institutet

The Personalised Cancer Medicine (PCM)-program at Karolinska Institutet (KI) is a research-based initiative to implement modern precision cancer medicine.

The purpose of the program is to facilitate PCM-related cancer research, aiming at future personalised cancer management in clinical routine practice. Achieved by catalysing synergies between existing and developing research and health care.

One aim is to develop a comprehensive pipeline for early clinical trials, as one instrumental core facility in a future Comprehensive Cancer Centre (CCC) at KI and the University Hospital. A CCC will be the basis for translational cancer research involving the “Theme Cancer” of the New Karolinska Hospital and the basic cancer research of KI.

The PCM program was initiated in 2014 with funding from Radiumhemmets Forskningsfonder. Professors Ingemar Ernberg and Rolf Lewensohn together with a steering group appointed by the KICancer Research Network chair the program. Claes Karlsson, MD, PhD, serves as the program director since december 2015.


The PCM Program has been granted financial support from Radiumhemmets research funds for continuing the development of PCM at Karolinska Institutet and Karolinska University hospital. A major effort will be international collaborations with Cancer Core Europe...

Generous Continuous Support From The Cancer Research Funds of Radiumhemmet

The KICancer Network with The PCM Program has been granted financial support for the development of Molecular Pathology and Early Clinical Trials at Karolinska. Furthermore this grant facilitates the PCM Program efforts in supporting Karolinska Institutets and the...

Second National PCM Workshop

Second National PCM Workshop on 17th of November Nobel Forum Karolinska Institutet. Bringing the top oncologists in Sweden to discuss the future of Precision Medicine in Cancer, ongoing research and infrastructure efforts. For invitations please contact

National PCM-workshop

The first National Workshop on PCM was held in Stockholm on the 6th of April 2016. A meeting with prominent figures within the translational cancer research community in Sweden initiating a discussion that emphasizes innovations, their translations and validation of...

KI member of Cancer Core Europe

Karolinska Institutet is one of six members in the transnational initiative Cancer Core Europe. This group brings leading cancer centres together with the primary objective to harmonize cancer research and care in Europe. Cancer Core Europe was formed as through the...

Four Pilot projects funded by PCM Program

PRESSRELEASE "Modern cancer research requires new and advanced infrastructures" - The objective of the PCM Program is to create the best possible conditions for internationally competitive research in individualized cancer treatment. Having co-funded four promising...

Program director appointed

MD Phd Claes Karlsson appointed program director for the PCM Program starting december 2015.